Clinical Research Institute is categorized under Medical Research in Minneapolis, MN and active since 1985.
Clinical Research Institute was established in 1985, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Harold Kaiser, President at the company’s single location by writing to 825 Nicollet Mall # 1135, Minneapolis, Minnesota MN 55402 or by phoning (612) 333-2200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Clinical Research Institute |
Contact Person: | Harold Kaiser, President |
Address: | 825 Nicollet Mall # 1135, Minneapolis, Minnesota 55402 |
Phone Number: | (612) 333-2200 |
Website Address: | criminnesota.com |
Annual Revenue (USD): | Unknown |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 5417115 |
Share This Business: |
Clinical Research Institute was started in 1985 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Harold Kaiser, President for inquiries that concern Clinical Research Institute by calling the company number (612) 333-2200, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Research Institute can be found at the coordinates 44.975598,-93.27322 as well as the street address 825 Nicollet Mall # 1135 in Minneapolis, Minnesota 55402.
For its online presence, you may visit Clinical Research Institute’s website at criminnesota.com and engage with its social media outlets through on Twitter and on Facebook.